You have read all your free articles, to continue reading subscribe to read the rest of this content.
DanDrit Biotech A/S has signed a contract of collaboration with the University Hospital IRCCS "San Martino". The collaboration relates to a Phase III adjuvant study of DanDrit's vaccine in patients with no evidence of disease ("NED") stage IV colorectal cancer ("CRC"). The primary goal of the stAlready a subscriber Login You…
NLSDays 2022, taking place at Malmömässan on September 28-29, will offer hot topics, inspiring discussions, and not least, opportunities for the life science community to meet, mingle and create business synergies. Meet Nordic Life Science at NLSDays We will participate in and cover the NLSDays-Already a subscriber Login You have…
Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IO. The national research and innovation project Cancer IO started in May as a part of Business Finland’s Personalized Health Program. The project will develop new solutAlready a subscriber Login You have read…
The Institute for Molecular Medicine Finland (FIMM), at the University of Helsinki and UPM Biochemicals have started a joint research project with the purpose of investigating the applicability of UPM's new cellulose-based gel material for cancer research. The project focuses on growing cancer ceAlready a subscriber Login You have read…
